XVIVO: The European heart launch is delayed for 6-12 months
29 juli, 13:41
29 juli, 13:41
The delayed launch is a setback for both XVIVO, patients and specialist centers waiting to use the solution. The remaining CE approval clearance relates to the perfusion solution. We look forward to a more detailed timetable at the Q3 report in October.
29 juli, 13:41
The delayed launch is a setback for both XVIVO, patients and specialist centers waiting to use the solution. The remaining CE approval clearance relates to the perfusion solution. We look forward to a more detailed timetable at the Q3 report in October.
Handelskrig
Apple
Analys
Handelskrig
Apple
Analys
1 DAG %
Senast
Kempower
Igår, 12:28
Laddat för tillväxt i Kempower
OMX Stockholm 30
1 DAG %
Senast
2 533,59